Ubiquitination/ Proteasome
Once the substrate protein is labeled, proteasome will bind to a polyubiquitin chain, allowing the degradation of the labeled protein. The polyubiquitinated target protein is then recognized and degraded by the 26S proteasome. Deubiquitinating enzymes (DUBs) reverse the process of ubiquitination by removing ubiquitin from its substrate protein. Dysregulation of the ubiquitin-proteasome system has been linked to cancer, diabetes, cardiovascular and neurodegenerative diseases etc.
- A4007 MLN97083 CitationTarget: ProteasomeSummary: Proteasome inhibitor
- A2601 Aclacinomycin ATarget: TopoisomerasesSummary: Topoisomerase I and II inhibitor
- A2604 CelastrolTarget: ProteasomeSummary: Antioxidant, anti-inflammatory and immunosuppressive agent
- A2578 Clasto-Lactacystin β-lactoneTarget: ProteasomeSummary: Proteasome inhibitor
- A4008 MLN2238Summary: β5 site of the 20S proteasome inhibitor
- A4009 CEP-187701 CitationSummary: Proteasome inhibitor
- A4014 Artemether (SM-224)Summary: Semi-synthetic derivative of artemisinin
- A4083 Rocilinostat (ACY-1215)1 CitationTarget: Histone Deacetylases (HDACs)Summary: Selective HDAC6 inhibitor
- A2583 Lactacystin (Synthetic)1 CitationTarget: ProteasomeSummary: Proteasome inhibitor
- A2571 Pepstatin A1 CitationTarget: Cathepsins|Renin|HIV proteases|PepsinsSummary: Aspartic protease inhibitor